$1.31
Value $137M
DH and MSFT stock compared: price, dividend, valuation and results, from SEC filings.
$1.31
Value $137M
$523.88
Value $3.89T
Definitive Healthcare (DH) has a market value of $137M and Microsoft (MSFT) $3.89T. Over the last year, with dividends, DH moved -51.8% and MSFT +3.3%. Dividend yield: DH none, MSFT 0.69%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
DH$137M
MSFT$3.89T
MSFT is 28,424 times DH
Revenue, 12 months
DH$227M
MSFT$346B
MSFT is 1,524 times DH
Net income, 12 months
DH-$157M
MSFT$143B
Operating margin
DH-105.4%
MSFT47.1%
152.5 points apart
ROIC
DH-44.0%
MSFT28.7%
72.7 points apart
P/E
DH–
MSFT27.3
Dividend yield
DH0.0%
MSFT0.7%
0.7 points apart
5-year return
DH-96.9%
MSFT+62.1%
159.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
DH-96.9%
MSFT+62.1%
| Period | DHWith dividends | MSFTWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -51.8%Price -51.8% | +3.3%Price +2.5% |
| 3 years since November 13, 2023 | -82.6%-44.2% a yearPrice -82.6% | +46.2%+13.5% a yearPrice +42.9% |
| 5 years since November 12, 2021 | -96.9%-50.0% a yearPrice -96.9% | +62.1%+10.1% a yearPrice +55.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
DHDefinitive HealthcareMSFTMicrosoft
| Price | $1.31 | $523.88 |
|---|---|---|
| Market value | $137M | $3.89T |
| Enterprise value (EV) | $105M | $3.93T |
| P/E | – | 27.3 |
| P/E, 5-year median | – | 35.2 |
| P/B | 0.7 | 8.3 |
| EV/EBIT | – | 24.1 |
| Free cash flow yield | 17.7% | 1.5% |
| Revenue, 12 months | $227M | $346B |
|---|---|---|
| Net income, 12 months | -$157M | $143B |
| Free cash flow, 12 months | $24M | $60.0B |
| Earnings per share, 12 months | -$1.51 | $19.16 |
| Revenue growth, year on year | -4.2% | 17.8% |
| Revenue growth a year, past | +15.3%over 5 years | +14.6%over 5 years |
| EPS growth a year, past | – | +17.4%over 5 years |
| Gross margin | 75.4% | 67.7% |
|---|---|---|
| Operating margin | -105.4% | 47.1% |
| Net margin | -69.2% | 41.2% |
| ROIC | -44.0% | 28.7% |
| ROE | -58.9% | 34.3% |
| Cash | $190M | $64.5B |
|---|---|---|
| Total debt | $164M | $134B |
| Net debt / EBITDA | – | 0.2 |
| Interest cover | -22.2× | 50.6× |
| Dividend yield | – | 0.7% |
|---|---|---|
| Dividend per share, 12 months | – | $3.64 |
| Dividend growth a year, past | – | +10.2%over 5 years |
| Buyback yield | 36.1% | 0.6% |
| Shareholder yield | 36.1% | 1.3% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Microsoft ($3.89T) is about 28,424.1 times Definitive Healthcare ($137M), at today's prices.
Since November 12, 2021, DH's price moved -96.9% and MSFT's +55.6%. With dividends: DH -96.9% (-50.0% a year), MSFT +62.1% (+10.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Definitive Healthcare and 0.69% for Microsoft. Over the last twelve months they paid – and $3.64 per share.
Over the last twelve months, the net margin was -69.2% for Definitive Healthcare and 41.2% for Microsoft, and the operating margin -105.4% and 47.1%. Revenue was $227M and $346B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.